New applications of magnetic resonance imaging for thoracic oncology

Seminars in Respiratory and Critical Care Medicine

Volumn 35, Issue 1, 2014, Pages 27-40

  Ohno, Yoshiharu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CT; lung; mediastinum; MRI; oncology; pleura

Indexed keywords

ARTICLE; BONE SCINTISCANNING; BREATH HOLDING; BREATHING PATTERN; CANCER SCREENING; CANCER STAGING; CARDIAC GATED IMAGING; CLINICAL PRACTICE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ELECTROCARDIOGRAM; HUMAN; LUNG CANCER; LUNG FUNCTION; LUNG NODULE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALIGNANT MESOTHELIOMA; MEDIASTINUM TUMOR; META ANALYSIS (TOPIC); MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; RESPIRATORY GATED IMAGING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX CANCER; THORAX RADIOGRAPHY; THYMUS HYPERPLASIA; TUMOR DIFFERENTIATION; TUMOR INVASION; WHOLE BODY MRI;

HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MEDIASTINAL NEOPLASMS; MESOTHELIOMA; NEOPLASM STAGING; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893326101     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0033-1363449     Document Type: Article

References (104)

1. Henschke C. I., McCauley D. I., Yankelevitz D. F., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet: 1999; 354 (9173): 99 105 (Pubitemid 29313143)
2. Swensen S. J., Jett J. R., Hartman T. E., et al. CT screening for lung cancer: five-year prospective experience. Radiology: 2005; 235 1 259 265 (Pubitemid 40432263)
3. Tuddenham W. J. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol: 1984; 143 3 509 517 (Pubitemid 14066648)
4. Aberle D. R., Adams A. M., Berg C. D., et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med: 2011; 365 5 395 409
5. Church T. R.; National Lung Screening Trial Executive Committee. Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol: 2003; 10 6 713 715 (Pubitemid 36628919)
6. Hansell D. M., Bankier A. A., MacMahon H., McLoud T. C., Müller N. L., Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology: 2008; 246 3 697 722
7. Patz E. F. Jr, Lowe V. J., Hoffman J. M., et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology: 1993; 188 2 487 490 (Pubitemid 23216276)
8. Dewan N. A., Gupta N. C., Redepenning L. S., Phalen J. J., Frick M. P. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest: 1993; 104 4 997 1002 (Pubitemid 23306039)
9. Croft D. R., Trapp J., Kernstine K., et al. FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer: 2002; 36 3 297 301 (Pubitemid 34497130)
10. Chun E. J., Lee H. J., Kang W. J., et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer: 2009; 65 2 180 186
11. Sakai F., Sone S., Maruyama A., et al. Thin-rim enhancement in Gd-DTPA-enhanced magnetic resonance images of tuberculoma: a new finding of potential differential diagnostic importance. J Thorac Imaging: 1992; 7 3 64 69
12. Sakai F., Sone S., Kiyono K., et al. MR of pulmonary hamartoma: pathologic correlation. J Thorac Imaging: 1994; 9 1 51 55 (Pubitemid 24017206)
13. Fujimoto K., Meno S., Nishimura H., Hayabuchi N., Hayashi A. Aspergilloma within cavitary lung cancer: MR imaging findings. AJR Am J Roentgenol: 1994; 163 3 565 567 (Pubitemid 24294362)
14. Blum U., Windfuhr M., Buitrago-Tellez C., Sigmund G., Herbst E. W., Langer M. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest: 1994; 106 4 1156 1161 (Pubitemid 24309556)
15. Chung M. H., Lee H. G., Kwon S. S., Park S. H. MR imaging of solitary pulmonary lesion: emphasis on tuberculomas and comparison with tumors. J Magn Reson Imaging: 2000; 11 6 629 637 (Pubitemid 30350306)
16. Gaeta M., Minutoli F., Ascenti G., et al. MR white lung sign: incidence and significance in pulmonary consolidations. J Comput Assist Tomogr: 2001; 25 6 890 896 (Pubitemid 33091666)
17. Gaeta M., Vinci S., Minutoli F., et al. CT and MRI findings of mucin-containing tumors and pseudotumors of the thorax: pictorial review. Eur Radiol: 2002; 12 1 181 189 (Pubitemid 36943936)
18. Ohno Y., Sugimura K., Hatabu H. MR imaging of lung cancer. Eur J Radiol: 2002; 44 3 172 181 (Pubitemid 35430202)
19. Sieren J. C., Ohno Y., Koyama H., Sugimura K., McLennan G. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging: 2010; 32 6 1353 1369
20. Kono M., Adachi S., Kusumoto M., Sakai E. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging: 1993; 8 1 18 26 (Pubitemid 23144041)
21. Kusumoto M., Kono M., Adachi S., et al. Gadopentetate-dimeglumine- enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. Invest Radiol: 1994; 29 02 S255 S256 (Pubitemid 24221128)
22. Uto T., Takehara Y., Nakamura Y., et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology: 2009; 252 1 247 254
23. Koyama H., Ohno Y., Kono A., et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol: 2008; 18 10 2120 2131
24. Mori T., Nomori H., Ikeda K., et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol: 2008; 3 4 358 364 (Pubitemid 351489475)
25. Satoh S., Kitazume Y., Ohdama S., Kimula Y., Taura S., Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol: 2008; 191 2 464 470
26. Cronin P., Dwamena B. A., Kelly A. M., Carlos R. C. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology: 2008; 246 3 772 782
27. Acker M. R., Burrell S. C. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol: 2005; 33 2 69 74, quiz 75-77 (Pubitemid 44783741)
28. Bruzzi J. F., Munden R. F. PET/CT imaging of lung cancer. J Thorac Imaging: 2006; 21 2 123 136 (Pubitemid 43904260)
29. Kligerman S., Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT. AJR Am J Roentgenol: 2009; 193 5 1203 1211
30. Webb W. R., Gatsonis C., Zerhouni E. A., et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology: 1991; 178 3 705 713
31. White C. S. MR evaluation of the pericardium and cardiac malignancies. Magn Reson Imaging Clin N Am: 1996; 4 2 237 251 (Pubitemid 26153164)
32. Wong J., Haramati L. B., Rozenshtein A., Yanez M., Austin J. H. Non-small-cell lung cancer: practice patterns of extrathoracic imaging. Acad Radiol: 1999; 6 4 211 215 (Pubitemid 32667411)
33. Sakai S., Murayama S., Murakami J., Hashiguchi N., Masuda K. Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr: 1997; 21 4 595 600 (Pubitemid 27432699)
34. Murata K., Takahashi M., Mori M., et al. Chest wall and mediastinal invasion by lung cancer: evaluation with multisection expiratory dynamic CT. Radiology: 1994; 191 1 251 255 (Pubitemid 24098241)
35. Takahashi K., Furuse M., Hanaoka H., et al. Pulmonary vein and left atrial invasion by lung cancer: assessment by breath-hold gadolinium-enhanced three-dimensional MR angiography. J Comput Assist Tomogr: 2000; 24 4 557 561 (Pubitemid 32204324)
36. Ohno Y., Adachi S., Motoyama A., et al. Multiphase ECG-triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging: 2001; 13 2 215 224 (Pubitemid 32066658)
37. Boiselle P. M., Patz E. F. Jr, Vining D. J., Weissleder R., Shepard J. A., McLoud T. C. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics: 1998; 18 5 1061 1069 (Pubitemid 128466875)
38. Takenaka D., Ohno Y., Hatabu H., et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol: 2002; 44 3 216 224 (Pubitemid 35430207)
39. Gückel C., Schnabel K., Deimling M., Steinbrich W. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology: 1996; 200 3 681 686 (Pubitemid 26282263)
40. Ohno Y., Hatabu H., Takenaka D., Adachi S., Kono M., Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology: 2002; 224 2 503 511 (Pubitemid 34809134)
41. Fujimoto K., Abe T., Müller N. L., et al. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis. Radiology: 2003; 227 3 786 793 (Pubitemid 36583038)
42. Ohno Y., Hatabu H., Takenaka D., et al. Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung. Eur J Radiol: 2004; 52 2 144 150 (Pubitemid 39361114)
43. Schaefer J. F., Vollmar J., Schick F., et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology: 2004; 232 2 544 553 (Pubitemid 38971298)
44. Schaefer J. F., Schneider V., Vollmar J., et al. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer: 2006; 53 1 39 49 (Pubitemid 43831358)
45. Kono R., Fujimoto K., Terasaki H., et al. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol: 2007; 188 1 26 36 (Pubitemid 46012486)
46. Ohno Y., Koyama H., Takenaka D., et al. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging: 2008; 27 6 1284 1295 (Pubitemid 351770679)
47. Sobin L., Gospodarowicz M., Wittekind C. TNM Classification of Malignant Tumors. 7th ed. New York, NY Wiley-Liss: 2009
48. Marom E. M., Erasmus J. J., Patz E. F. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer: 2000; 28 3 187 202 (Pubitemid 30254227)
49. Vansteenkiste J. F. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl: 2002; 35 49s 60s
50. Ohno Y., Hatabu H., Takenaka D., et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology: 2004; 231 3 872 879 (Pubitemid 38668111)
51. Ohno Y., Koyama H., Nogami M., et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging: 2007; 26 4 1071 1080 (Pubitemid 47548169)
52. Yi C. A., Shin K. M., Lee K. S., et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology: 2008; 248 2 632 642
53. Morikawa M., Demura Y., Ishizaki T., et al. The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax. J Nucl Med: 2009; 50 1 81 87
54. Ohno Y., Koyama H., Yoshikawa T., et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology: 2011; 261 2 605 615
55. Nomori H., Mori T., Ikeda K., et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg: 2008; 135 4 816 822 (Pubitemid 351417933)
56. Hasegawa I., Boiselle P. M., Kuwabara K., Sawafuji M., Sugiura H. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging: 2008; 23 3 157 161
57. 18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol: 2012; 81 1 178 182
58. Quint L. E., Tummala S., Brisson L. J., et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg: 1996; 62 1 246 250 (Pubitemid 26239872)
59. Pantel K., Izbicki J., Passlick B., et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet: 1996; 347 (9002): 649 653 (Pubitemid 26076131)
60. Silvestri G. A., Gould M. K., Margolis M. L., et al. American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest: 2007; 132 (3 Suppl): S178 S201
61. Simon G. R., Turrisi A.; American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest: 2007; 132 3 Suppl S324 S339
62. Samson D. J., Seidenfeld J., Simon G. R., et al. American College of Chest Physicians. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest: 2007; 132 3 Suppl S314 S323
63. Walker R., Kessar P., Blanchard R., et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging: 2000; 11 4 343 350 (Pubitemid 30185873)
64. Antoch G., Vogt F. M., Freudenberg L. S., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA: 2003; 290 24 3199 3206 (Pubitemid 38020681)
65. Lauenstein T. C., Goehde S. C., Herborn C. U., et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology: 2004; 233 1 139 148 (Pubitemid 39280968)
66. Goehde S. C., Hunold P., Vogt F. M., et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR Am J Roentgenol: 2005; 184 2 598 611 (Pubitemid 46657273)
67. Schmidt G. P., Haug A. R., Schoenberg S. O., Reiser M. F. Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol: 2006; 16 6 1216 1225 (Pubitemid 43834707)
68. Charles-Edwards E. M., deSouza N. M. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging: 2006; 6 135 143
69. Ohno Y., Koyama H., Nogami M., et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging: 2007; 26 3 498 509 (Pubitemid 350194569)
70. Ohno Y., Koyama H., Onishi Y., et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology: 2008; 248 2 643 654
71. Takenaka D., Ohno Y., Matsumoto K., et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging: 2009; 30 2 298 308
72. Sommer G., Wiese M., Winter L., et al. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol: 2012; 22 12 2859 2867
73. Takahashi K., Al-Janabi N. J. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging: 2010; 32 6 1325 1339
74. Inaoka T., Takahashi K., Iwata K., et al. Evaluation of normal fatty replacement of the thymus with chemical-shift MR imaging for identification of the normal thymus. J Magn Reson Imaging: 2005; 22 3 341 346 (Pubitemid 41298320)
75. Linegar A. G., Odell J. A., Fennell W. M., et al. Massive thymic hyperplasia. Ann Thorac Surg: 1993; 55 5 1197 1201 (Pubitemid 23164848)
76. Takahashi K., Inaoka T., Murakami N., et al. Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging. AJR Am J Roentgenol: 2003; 180 5 1265 1269 (Pubitemid 36504612)
77. Inaoka T., Takahashi K., Mineta M., et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology: 2007; 243 3 869 876 (Pubitemid 46799443)
78. Yamamuro M., Gerbaudo V. H., Gill R. R., Jacobson F. L., Sugarbaker D. J., Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol: 2007; 64 3 356 366 (Pubitemid 350116492)
79. Falaschi F., Battolla L., Mascalchi M., et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol: 1996; 166 4 963 968 (Pubitemid 26102085)
80. Robinson B. W., Lake R. A. Advances in malignant mesothelioma. N Engl J Med: 2005; 353 15 1591 1603 (Pubitemid 41434638)
81. Curran D., Sahmoud T., Therasse P., van Meerbeeck J., Postmus P. E., Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol: 1998; 16 1 145 152 (Pubitemid 28041592)
82. Helm E. J., Matin T. N., Gleeson F. V. Imaging of the pleura. J Magn Reson Imaging: 2010; 32 6 1275 1286
83. Hierholzer J., Luo L., Bittner R. C., et al. MRI and CT in the differential diagnosis of pleural disease. Chest: 2000; 118 3 604 609
84. Heelan R. T., Rusch V. W., Begg C. B., Panicek D. M., Caravelli J. F., Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol: 1999; 172 4 1039 1047 (Pubitemid 29505636)
85. Patz E. F. Jr, Shaffer K., Piwnica-Worms D. R., et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol: 1992; 159 5 961 966
86. Sugarbaker D. J., Flores R. M., Jaklitsch M. T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg: 1999; 117 1 54 63, discussion 63-65
87. Gill R. R., Umeoka S., Mamata H., et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol: 2010; 195 2 W125-30
88. Pierce R. J., Copland J. M., Sharpe K., Barter C. E. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med: 1994; 150 4 947 955 (Pubitemid 24318018)
89. Bolliger C. T., Jordan P., Solèr M., et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med: 1995; 151 5 1472 1480
90. Wyser C., Stulz P., Solèr M., et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med: 1999; 159 5 Pt 1 1450 1456 (Pubitemid 29227853)
91. Mazzone P. J., Arroliga A. C. Lung cancer: Preoperative pulmonary evaluation of the lung resection candidate. Am J Med: 2005; 118 6 578 583 (Pubitemid 40732694)
92. Colice G. L., Shafazand S., Griffin J. P., Keenan R., Bolliger C. T.; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest: 2007; 132 (3 Suppl): 161S 177S (Pubitemid 47502806)
93. Iwasawa T., Saito K., Ogawa N., Ishiwa N., Kurihara H. Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung. J Magn Reson Imaging: 2002; 15 6 685 692 (Pubitemid 34606503)
94. Ohno Y., Hatabu H., Higashino T., et al. Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. AJR Am J Roentgenol: 2004; 182 1 73 78 (Pubitemid 38017720)
95. Ohno Y., Koyama H., Nogami M., et al. Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol: 2007; 189 2 400 408 (Pubitemid 47195926)
96. Ohno Y., Koyama H., Nogami M., et al. State-of-the-art radiological techniques improve the assessment of postoperative lung function in patients with non-small cell lung cancer. Eur J Radiol: 2011; 77 1 97 104
97. Ohno Y., Hatabu H., Higashino T., et al. Oxygen-enhanced MR imaging: correlation with postsurgical lung function in patients with lung cancer. Radiology: 2005; 236 2 704 711 (Pubitemid 41023462)
98. Eisenhauer E. A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer: 2009; 45 2 228 247
99. Ohno Y., Nogami M., Higashino T., et al. Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy. J Magn Reson Imaging: 2005; 21 6 775 783 (Pubitemid 40770870)
100. de Langen A. J., van den Boogaart V., Lubberink M., et al. Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med: 2011; 52 1 48 55
101. Giesel F. L., Bischoff H., von Tengg-Kobligk H., et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest: 2006; 129 6 1570 1576 (Pubitemid 43894988)
102. Giesel F. L., Choyke P. L., Mehndiratta A., et al. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol: 2008; 15 5 563 570 (Pubitemid 351509763)
103. Yabuuchi H., Hatakenaka M., Takayama K., et al. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology: 2011; 261 2 598 604
104. Ohno Y., Koyama H., Yoshikawa T., et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR Am J Roentgenol: 2012; 198 1 75 82